brand logo

Am Fam Physician. 2005;71(3):529-530

Clinical Question

Which treatments for persistent otitis media with effusion are beneficial?

Evidence-Based Answer

Treatments such as antibiotics, steroids, antihistamines/decongestants, and mucolytics afford no long-term benefit in the treatment of patients with otitis media with effusion (OME). [Strength of recommendation: A] Surgical treatments such as ventilation tubes and adenoidectomy improve hearing. [Strength of recommendation: A] However, surgery has conflicting effects on improving language development and behavior. [Strength of recommendation: B] There is inconclusive evidence that autoinflation of the eustachian tube with a nasal balloon improves resolution of OME. [Strength of recommendation: B]

Evidence Summary

OME is defined as middle ear effusion without acute inflammation. Many treatments have been recommended, although data supporting them are limited.

The results of three meta-analyses13 showed that antibiotics increased the resolution of OME in the short-term (less than one month). However, the results of a conflicting meta-analysis4 of only higher quality, placebo-controlled studies showed that antibiotic therapy resulted in no significant difference compared with placebo. One meta-analysis3 looked at outcomes beyond one month and showed no significant difference in resolution of OME.

The results of a well-designed systematic review5 of the use of steroids in patients with OME found that oral and nasal steroids do not have any significant benefit in the long-term (more than two weeks) when used alone or with antibiotics. A subsequent randomized controlled trial6 (RCT) of oral steroids given with antibiotics reached similar conclusions.

The results of meta-analyses on antihistamines/decongestants1 and mucolytics7 showed no benefit in clearance of OME. Another meta-analysis8 looked at opening the eustachian tubes by autoinflation with a nasal balloon. The methods of this meta-analysis were unclear, and the studies were generally of low quality. However, within a homogenous subgroup of three RCTs, the odds ratio for improvement of OME with autoinflation was 3.5 (95 percent confidence interval, 2.0 to 6.1). The number needed to treat was three. Unblinded outcome assessments led the authors of the meta-analysis to not recommend autoinflation for clinical practice.

Surgical options include ventilation tubes, adenoidectomy, and tonsillectomy. The results of a systematic review9 of children with OME showed slight improvement (less than 12 dB) in hearing with the use of ventilation tubes or adenoidectomy alone. Combining the procedures offered little additional benefit. There were no data supporting tonsillectomy in the treatment of OME. A subsequent RCT10 of children with OME confirmed this conclusion, showing a 5 to 6 dB improvement in hearing with ventilation tubes at six and 12 months postprocedure. The results of two additional RCTs11,12 using the same group of children showed that early insertion of ventilation tubes improves language development and decreases behavior problems at nine months postprocedure compared with watchful waiting. However, 85 percent of the children in the watchful-waiting group received ventilation tubes by 18 months, and there no longer were significant differences in outcomes.

It is important to note that the inclusion criteria for these RCTs were baseline disruptions to speech, language, learning, and behavior. The results of other RCTs without these inclusion criteria showed no difference in language development or quality of life with early insertion of ventilation tubes versus watchful waiting for periods of six to 12 months. Furthermore, the majority of children in the watchful-waiting groups in these latter studies avoided surgery by the end of the follow-up periods.1317

Recommendations from Others

A recent evidence-based practice guideline18 from the American Academy of Family Physicians, the American Academy of Pediatrics, and the American Academy of Otolaryngology–Head and Neck Surgery recommends against the use of antibiotics, steroids, antihistamine/decongestants, mucolytics, and autoinflation in the routine treatment of OME. Surgery for persistent OME should be reserved for use in children with significant hearing loss, persistent symptoms, risk factors for developmental difficulties, or structural damage to the tympanic membrane or middle ear. Antibiotics, with or without steroids, can be considered if the parents or caregivers are strongly opposed to surgery.

Clinical Commentary

Many patients and parents desire active treatment of OME, and treatment is still advocated by many physicians on the basis of habit, anecdote, or tradition. Therefore, it may be difficult for some physicians to not treat OME. Nevertheless, the evidence does not support most treatments. Instead of prescribing medicines, physicians must develop tracking and intervention systems to monitor children with OME over time and recognize complications such as significant hearing loss and developmental delays. Surgery should be considered for patients with these conditions. However, the optimal timing for surgery is unknown.

Clinical Inquiries provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to or email:

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of FPIN’s Clinical Inquiries published in AFP is available at

Continue Reading

More in AFP

More in Pubmed

Copyright © 2005 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.